Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Nhu, Nguyen Thi Quynh ^a   Ha, Dang Thi Minh ^a,b   Anh, Nguyen D ^a   Thu, Do Dang Anh ^a   Duong, Tran N ^b   Quang, Nguyen D ^b   Lan, Nguyen Thi Ngoc ^b   Van Quyet, Tran ^b   Tuyen, Nguyen Thi Bich ^b   Ha, Vo T ^b   Giang, Do C ^a,b   Dung, Nguyen H ^b   Wolbers, Marcel ^a,c   Farrar, Jeremy ^a,c   Caws, Maxine ^a,c  

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease   (Viet Nam)

^c CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Childhood; GeneXpert MTB RIF; MODS; Pediatric; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN;

ADOLESCENT; ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASSAY; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; COST; CULTURE TECHNIQUE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; EVALUATION; HOSPITAL; HUMAN; LABORATORY DIAGNOSIS; LIQUID CULTURE; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY ASSAY; MYCOBACTERIAL GROWTH FACTOR INDICATOR CULTURE; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRESCHOOL CHILD; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; STAINING; STORAGE; TUBERCULOSIS; VIET NAM; ZIEHL NEELSEN SMEAR; DIAGNOSTIC KIT; DRUG EFFECT; INFANT; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIAL SENSITIVITY TEST; MICROBIOLOGICAL EXAMINATION; MYCOBACTERIUM TUBERCULOSIS; NEWBORN; REPRODUCIBILITY;

ADOLESCENT; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

MLCS; MLOWN;

EID: 84872593148     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-31     Document Type: Article

References (26)

1. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004, 8(5):636-647.
2. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163(9):1009-1021. 10.1001/archinte.163.9.1009, 12742798.
3. Zar HJ, Hanslo D, Apolles P, Swingler G, Hussey G. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: a prospective study. Lancet 2005, 365(9454):130-134. 10.1016/S0140-6736(05)17702-2, 15639294.
4. Connell TG, Zar HJ, Nicol MP. Advances in the diagnosis of pulmonary tuberculosis in HIV-infected and HIV-uninfected children. J Infect Dis 2011, 204(Suppl 4):S1151-1158. 10.1093/infdis/jir413, 3192545, 21996697.
5. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006, 173(10):1078-1090. 10.1164/rccm.200511-1809SO, 16484674.
6. Sandgren A, Cuevas LE, Dara M, Gie RP, Grzemska M, Hawkridge A, Hesseling AC, Kampmann B, Lienhardt C, Manissero D, et al. Childhood tuberculosis: progress requires advocacy strategy now. Eur Respir J 2012, 40(2):294-297. 10.1183/09031936.00187711, 3409406, 22337859.
7. Marais BJ, Gie RP, Hesseling AC, Schaaf HS, Lombard C, Enarson DA, Beyers N. A refined symptom-based approach to diagnose pulmonary tuberculosis in children. Pediatrics 2006, 118(5):e1350-1359. 10.1542/peds.2006-0519, 17079536.
8. Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, et al. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J Infect Dis 2012, 205(suppl 2):S199-208. 10.1093/infdis/jis008, 22448023.
9. Palomino JC. Current developments and future perspectives for TB diagnostics. Future Microbiol 2012, 7(1):59-71. 10.2217/fmb.11.133, 22191447.
10. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006, 355(15):1539-1550. 10.1056/NEJMoa055524, 1780278, 17035648.
11. Ha DT, Lan NT, Wolbers M, Duong TN, Quang ND, Thi Van Thinh T, Thi Hong Ngoc L, Thi Ngoc Anh N, Van Quyet T, Thi Bich Tuyen N, et al. Microscopic observation drug susceptibility assay (MODS) for early diagnosis of tuberculosis in children. PLoS One 2009, 4(12):e8341. 10.1371/journal.pone.0008341, 2791864, 20020056.
12. Oberhelman RA, Soto-Castellares G, Caviedes L, Castillo ME, Kissinger P, Moore DA, Evans C, Gilman RH. Improved recovery of Mycobacterium tuberculosis from children using the microscopic observation drug susceptibility method. Pediatrics 2006, 118(1):e100-106. 10.1542/peds.2005-2623, 16751616.
13. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010, 48(7):2495-2501. 10.1128/JCM.00128-10, 2897495, 20504986.
14. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis. J Infect 2012, 64(6):580-588. 10.1016/j.jinf.2012.02.012, 22381459.
15. The Stop TB department WHO Roadmap for rolling out Xpert MTB/RIFfor rapid diagnosis of TB and MDR-TB 2010, available at http://www.who.int/tb/laboratory/roadmap_xpert_mtb-rif.pdf, The Stop TB department WHO.
16. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011, 11(11):819-824. 10.1016/S1473-3099(11)70167-0, 21764384.
17. World Health Organisation Global tuberculosis control 2011, Geneva, Switzerland: World health Organisation, WHO/HTM/TB/2011.16, World Health Organisation.
18. Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat World Population Prospects, The 2010 Revision. Accessed 28 May 2012. http://esa.un.org/unpd/wpp/index.htm.
19. World Health Organisation Global Tuberculosis Programme Laboratory service in tuberculosis control: part II. Microscopy 1998, Geneva, Switzerland: World Health Organisation, WHO/TB/98258, World Health Organisation Global Tuberculosis Programme.
20. Becton Dickinson BACTEC™ MGIT™ 960 SIRE kits for the antimycobacterial susceptibility testing of mycobacterium tuberculosis. Package insert Revision: 2010/10 Accessed 28 May 2012. http://www.bd.com/ds/productCenter/245123.asp, Becton Dickinson.
21. Agresti A, Caffo B. Simple and effective confidence intervals for proportions and difference of proportions result from adding two successes and two failures. Am Stat 2000, 54(4):280-288.
22. Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, Kowour D, Rojas-Ponce G, Kroidl A, Maboko L, et al. Increased and expedited case detection by xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012, 54(10):1388-1396. 10.1093/cid/cis190, 22474220.
23. Swaminathan S, Rekha B. Pediatric tuberculosis: global overview and challenges. Clin Infect Dis 2010, 50(Suppl 3):S184-194.
24. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377(9776):1495-1505. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
25. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011, 8(7):e1001067. 10.1371/journal.pmed.1001067, 3144215, 21818180.
26. Lawn SD, Nicol MP. Xpert(R) MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance. Future Microbiol 2011, 6(9):1067-1082. 10.2217/fmb.11.84, 3252681, 21958145.